Baxter International Inc (BAX) stock
BAXNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 9/306% above fair value
$25.76+0.22 (+0.86%)
Close on Nov 17, 2026Market cap $13.33BP/E –Yield 2.02%
Baxter International operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Baxter International's operating cash flow for the twelve months ending Sep 30, 2026 was $1.64B, up 119.0% year over year. For fiscal 2025 it was $845.00M, down 17.1% from the year before. Over ten years it grew -7.1% a year on average. The highest annual figure on record is $3.22B in fiscal 2014.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $845.00M | -17.1% |
| FY2024 | Dec 31, 2024 | $1.02B | -41.0% |
| FY2023 | Dec 31, 2023 | $1.73B | +42.5% |
| FY2022 | Dec 31, 2022 | $1.21B | -45.5% |
| FY2021 | Dec 31, 2021 | $2.22B | +19.0% |
| FY2020 | Dec 31, 2020 | $1.87B | -11.2% |
| FY2019 | Dec 31, 2019 | $2.10B | +4.3% |
| FY2018 | Dec 31, 2018 | $2.02B | +17.7% |
| FY2017 | Dec 31, 2017 | $1.71B | +3.6% |
| FY2016 | Dec 31, 2016 | $1.65B | -6.6% |
| FY2015 | Dec 31, 2015 | $1.77B | -44.9% |
| FY2014 | Dec 31, 2014 | $3.22B | +0.5% |
| FY2013 | Dec 31, 2013 | $3.20B | +3.0% |
| FY2012 | Dec 31, 2012 | $3.11B | +10.3% |
| FY2011 | Dec 31, 2011 | $2.82B | -6.2% |
| FY2010 | Dec 31, 2010 | $3.00B | +3.2% |
| FY2009 | Dec 31, 2009 | $2.91B | +15.7% |
| FY2008 | Dec 31, 2008 | $2.52B | +9.1% |
| FY2007 | Dec 31, 2007 | $2.31B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $558.00M | +135.4% |
| Q2 FY2026 | Jun 30, 2026 | $285.00M | +31.3% |
| Q1 FY2026 | Mar 31, 2026 | $213.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $584.00M | +19.7% |
| Q3 FY2025 | Sep 30, 2025 | $237.00M | -6.3% |
| Q2 FY2025 | Jun 30, 2025 | $217.00M | +88.7% |
| Q1 FY2025 | Mar 31, 2025 | -$193.00M | -218.4% |
| Q4 FY2024 | Dec 31, 2024 | $488.00M | -8.1% |
| Q3 FY2024 | Sep 30, 2024 | $253.00M | -30.7% |
| Q2 FY2024 | Jun 30, 2024 | $115.00M | -67.2% |
| Q1 FY2024 | Mar 31, 2024 | $163.00M | -66.0% |
| Q4 FY2023 | Dec 31, 2023 | $531.00M | +21.0% |
| Q3 FY2023 | Sep 30, 2023 | $365.00M | +25.9% |
| Q2 FY2023 | Jun 30, 2023 | $351.00M | +28.1% |
| Q1 FY2023 | Mar 31, 2023 | $479.00M | +130.3% |
| Q4 FY2022 | Dec 31, 2022 | $439.00M | -36.7% |
| Q3 FY2022 | Sep 30, 2022 | $290.00M | -57.0% |
| Q2 FY2022 | Jun 30, 2022 | $274.00M | -42.6% |
| Q1 FY2022 | Mar 31, 2022 | $208.00M | -44.8% |
| Q4 FY2021 | Dec 31, 2021 | $693.00M | -2.7% |
| Q3 FY2021 | Sep 30, 2021 | $675.00M | +32.4% |
| Q2 FY2021 | Jun 30, 2021 | $477.00M | +27.5% |
| Q1 FY2021 | Mar 31, 2021 | $377.00M | +38.6% |
| Q4 FY2020 | Dec 31, 2020 | $712.00M | -14.1% |
| Q3 FY2020 | Sep 30, 2020 | $510.00M | -27.2% |
| Q2 FY2020 | Jun 30, 2020 | $374.00M | -16.1% |
| Q1 FY2020 | Mar 31, 2020 | $272.00M | +112.5% |
| Q4 FY2019 | Dec 31, 2019 | $829.00M | +16.9% |
| Q3 FY2019 | Sep 30, 2019 | $701.00M | +47.3% |
| Q2 FY2019 | Jun 30, 2019 | $446.00M | +10.9% |
| Q1 FY2019 | Mar 31, 2019 | $128.00M | -70.2% |
| Q4 FY2018 | Dec 31, 2018 | $709.00M | +81.3% |
| Q3 FY2018 | Sep 30, 2018 | $476.00M | -21.3% |
| Q2 FY2018 | Jun 30, 2018 | $402.00M | -24.0% |
| Q1 FY2018 | Mar 31, 2018 | $430.00M | +127.5% |
| Q4 FY2017 | Dec 31, 2017 | $391.00M | -45.2% |
| Q3 FY2017 | Sep 30, 2017 | $605.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $529.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $189.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $713.00M | – |
See a number that looks wrong?